Synthetic Biologics Inc (NYSE MKT LLC:SYN)

Data as of Sep 19
 +0.02 / +1.16%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Synthetic Biologics, Inc. is a biotechnology company focused on the development of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases. It is developing an oral biologic to protect the gastrointestinal microflora from the effects of IV antibiotics for the prevention of C. diff infection, an oral treatment to reduce the impact of methane producing organisms on conditions such as constipation-predominant irritable bowel syndrome (C-IBS), a series of monoclonal antibodies for the treatment of Pertussis and Acinetobacter infections, and a biologic targeted at the prevention and treatment of a root cause of a subset of IBS. The company was founded by Steven H. Kanzer in January 2001 and is headquartered in Rockville, MD.

Contact Information

Synthetic Biologics, Inc.
155 Gibbs Street
Rockville Maryland 20850
P:(734) 332-7800
Investor Relations:



Other institutional8.41%
Mutual fund holders4.05%
Individual stakeholders29.12%

Top Executives

Jeffrey Lucero RileyPresident, Chief Executive Officer & Director
Charles Evan BallantyneChief Financial Officer, Secretary & Treasurer
John James MonahanExecutive Vice President-Research & Development
Joseph SlimanSenior VP-Clinical & Regulatory Affairs
Lara M. GuzmanSenior Director-Project Operations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.